For complete information on Gardasil, as promoted in Europe, you can obtain access to the authorisation details, product information and their assessment history via this link.
Gardasil-Product Information-FDA
Proper Name: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant Trade name: Gardasil Manufacturer: Merck & Co., Inc, License #0002 Product Information and Supporting Documents Approval History, Letters, Reviews, and Related Documents – Gardasil
Gardasil or Silgard Product Information Merck & Co.
Manufacturer, Merck & Co. To obtain product information on Gardasil or Silgard directly from the manufacturer, you can visit their website and search for product by name. Visit Merck’s database here.
Gardasil: Supplemental Biologics Licensing Application for Use in Anal Cancer Prevention
VRBPAC Briefing Document Presented by Merck on 17 November 2010 Human papillomaviruses (HPV) cause a significant burden of benign and malignant anogenital disease in men and women. The HPV-related anogenital cancers all develop through a common pathogenetic process of neoplastic change that begins with the necessary event of HPV infection. After cervical cancer, the anogenital […]
PRESCRIBING INFORMATION FOR GARDASIL
INDICATIONS AND USAGE GARDASIL is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine: Cervical, vulvar, and vaginal cancer caused by HPV types 16 and 18 Genital warts (condyloma acuminata) caused by HPV types […]
